Manulife Financial (MFC) Q2 2026: 21% Asia Core Earnings Growth Drives Diversified Portfolio Momentum
Manulife’s second quarter results highlight robust growth in Asia insurance earnings and strategic risk reduction through a novel long-term care reinsurance deal, underpinning sustained portfolio strength and capital discipline. Despite some insurance experience challenges in Canada and the U.S., the company’s diversified business model and AI-driven innovation fuel solid profitability and shareholder returns. The new reinsurance transaction preserves asset management benefits while materially de-risking legacy liabilities, signaling a strategic pivot toward organic portfolio management.
Summary
- Asia Insurance Leadership: Continued expansion driven by high-quality agency force and diversified sales channels.
- Strategic Risk Management: Innovative long-term care reinsurance reduces morbidity risk by 24%, enhancing capital efficiency.
- AI Integration and Product Innovation: Accelerated AI adoption and new high-net-worth solutions bolster competitive differentiation.
Business Overview
Manulife Financial Corporation operates as a diversified financial services company with key business segments including Insurance (Asia, Canada, U.S.) and Global Wealth and Asset Management (Global WAM). The company generates revenue through insurance premiums, investment income, and asset management fees, serving individual and institutional clients worldwide. Its insurance business focuses on life, health, and long-term care products, while Global WAM provides investment management and advisory services.
Performance Analysis
Manulife delivered strong financial results in Q2 2026, with core earnings rising 12% year-over-year to $1.9 billion, driven predominantly by a 21% increase in Asia’s core earnings to a record level. This growth was underpinned by broad-based contributions from key markets such as Hong Kong, Singapore, and Japan, reflecting the strength of its multi-channel distribution network and a high-quality agency force. The company’s insurance new business metrics also showed double-digit growth, with annualized premium equivalent (APE) sales up 21% and new business contractual service margin (CSM) rising 16%, supporting future earnings capacity.
Global WAM returned to net inflows of $0.4 billion, bolstered by institutional business strength and recent acquisitions, despite retirement and retail outflows. Core earnings in Global WAM increased 9%, aided by higher average assets under management and a 110 basis point expansion in core EBITDA margin to 31.2%. Conversely, Canada’s core earnings declined 10% due to unfavorable claims and expense experience, particularly in group insurance disability claims, although new business CSM grew 29%. The U.S. segment rebounded strongly with a 55% increase in core earnings, benefiting from improved claims experience and lower expected credit loss provisions.
- Geographic Earnings Mix: Asia accounted for a substantial share of growth, offsetting softness in Canada and volatility in the U.S.
- Insurance New Business Momentum: Double-digit growth in APE sales and new business CSM highlight effective distribution and product execution.
- Capital and Returns: Core return on equity improved by 130 basis points to 16.3%, supported by disciplined capital deployment and share buybacks.
The company’s adjusted book value per share increased 15% year-over-year, reaching $41.12, reflecting strong earnings growth and capital returns totaling $5.3 billion over the past 12 months. Manulife’s balance sheet remains robust with a LICAT ratio of 136% and a financial leverage ratio well below medium-term targets, providing ample financial flexibility.
Executive Commentary
"Our insurance businesses generated strong top line results with APE sales growth of 21% year over year supported by double-digit growth across all segments. Asia core earnings grew 21% to a record level, and Global WAM expanded its margin and generated positive net flows despite challenges in some channels. We continue to embed AI across our enterprise to enhance customer experience and operational efficiency, further differentiating our competitive position."
Phil Witherington, President and Chief Executive Officer
"This quarter, we delivered strong core earnings growth and maintained disciplined capital deployment, returning $2.6 billion to shareholders in the first half of 2026. Our expense efficiency ratio improved to 44.5%, below our medium-term target, even as we invest in AI and business growth. We remain on track to achieve our 18% core ROE target, supported by a consistent 2.5% share buyback program."
Colin Simpson, Chief Financial Officer
Strategic Positioning
1. Asia Market Leadership and Distribution Excellence
Manulife’s Asia segment demonstrated robust growth driven by a diversified multi-channel distribution network, including agency, bancassurance, and third-party channels. The company’s focus on scaling a high-quality agency force, supported by AI-enabled training through the Manulife Business Academy, has increased productivity with APE sales per active agent up over 30% year-over-year. The launch of innovative high-net-worth insurance products, including the first indexed Takaful solution for the Middle East and a participating life insurance product combined with asset-backed securities, further strengthens market differentiation.
2. Innovative Long-Term Care Reinsurance Transaction
The newly announced long-term care (LTC) reinsurance deal with Munich Re represents a full biometric risk transfer of $3.2 billion in reserves at an 80% quota share, reducing LTC morbidity risk by 24%. Unlike previous transactions, Manulife retains asset management responsibility, preserving earnings potential and capital generation from the underlying portfolio. The transaction carries a modest 5% negative seed on IFRS reserves but is expected to be capital neutral overall. This deal exemplifies Manulife’s strategic pivot toward organic risk management while retaining financial flexibility.
3. Accelerated AI Adoption and Enterprise Integration
Manulife was recognized as the number one life insurer for AI maturity for the second consecutive year by Evident, reflecting industry-leading AI integration. The company’s AI initiatives span underwriting automation (Manulife Automated Underwriting Decision Engine), document intelligence, and knowledge assistants in Global WAM, enhancing customer experience and operational efficiency. The rollout of a scalable enterprise AI platform enables reuse of AI capabilities across markets, accelerating innovation and value creation.
4. Global Wealth and Asset Management Growth and Margin Expansion
Global WAM posted 9% core earnings growth supported by record gross flows of $58.7 billion and positive net inflows driven by institutional mandates, including contributions from recent acquisitions CQS and Comvest. The expansion of ETF-based retail investment offerings in North America broadens client access to actively managed, outcome-oriented products. Despite retirement and retail outflows, the segment improved its core EBITDA margin by 110 basis points to 31.2%, reflecting operational leverage and disciplined expense management.
5. Focused Actions to Address Canadian Insurance Experience
Canada’s insurance segment faces challenges from unfavorable disability claims experience, notably related to mental health claims which tend to have longer durations. Manulife is investing in targeted interventions such as specialized case management, early intervention programs, and enhanced treatment access to improve health outcomes and manage claims duration. The company expects insurance experience to trend toward neutral by year-end and has the ability to reprice annually to manage margins, balancing growth and profitability.
Key Considerations
Manulife’s Q2 results underscore the strength of its diversified business model, but several key factors warrant investor attention:
- Asia’s Contribution and Regulatory Sensitivity: Asia remains the primary growth engine, but regulatory developments in Hong Kong and mainland China, particularly around offshore insurance and tax enforcement, require ongoing monitoring. Management expects manageable short-term impacts and continued structural growth.
- Long-Term Care Risk Management Shift: The biometric risk-only reinsurance deal marks a strategic shift from capital release-focused transactions to preserving asset management earnings while reducing morbidity risk, balancing risk and profitability.
- AI as a Growth and Efficiency Driver: Continued investment in AI is central to Manulife’s strategy, offering potential for sustainable margin improvement and enhanced customer experience across segments.
- Expense Efficiency and Investment Balance: While expense efficiency improved, ongoing investments in AI, digital capabilities, and business growth create a dynamic where efficiency gains must offset incremental spending.
- Canadian Insurance Experience and Pricing Flexibility: The segment’s unfavorable claims experience poses near-term margin pressure, but management’s targeted health programs and annual repricing provide mechanisms to restore profitability.
Risks
Manulife faces execution risks related to regulatory changes in Asia, particularly in Hong Kong’s offshore insurance market, which could affect sales and earnings. Insurance experience volatility in Canada and the U.S., especially disability and life claims, may pressure margins if adverse trends persist. The long-term care reinsurance transaction’s modest earnings impact and limited capital release may constrain near-term capital deployment flexibility. Additionally, macroeconomic factors such as market volatility, interest rate fluctuations, and fee compression in asset management could impact profitability.
Forward Outlook
For Q3 2026, Manulife anticipates continued momentum in Asia insurance sales and new business value, with ongoing focus on managing insurance experience in Canada and the U.S. The company expects Global WAM to sustain positive net inflows driven by institutional mandates, while managing retirement and retail outflows. Expense efficiency is targeted to improve modestly, supported by AI initiatives.
- Core EPS growth expected to continue, supported by organic business growth and share buybacks.
- Capital deployment to shareholders will maintain a 2.5% share buyback program aligned with the 18% core ROE medium-term target.
Management highlighted that the long-term care reinsurance transaction closes in Q4 2026, subject to regulatory approvals, and that organic management initiatives will be emphasized to improve risk-adjusted returns on the LTC portfolio.
Takeaways
Manulife’s Q2 2026 results reinforce its position as a diversified, innovation-driven insurer and asset manager with a clear strategic focus on growth, risk management, and AI integration.
- Asia’s Strong Earnings Momentum: The segment’s double-digit growth driven by agency force quality and product innovation is critical to sustaining Manulife’s overall earnings trajectory.
- Risk Transfer Innovation Balances Capital and Earnings: The biometric risk-only LTC reinsurance deal demonstrates a nuanced approach to managing legacy risks without sacrificing asset-related earnings, signaling a strategic pivot in portfolio management.
- AI Leadership Supports Competitive Advantage: Industry recognition and scalable AI solutions position Manulife to enhance operational efficiency and customer engagement, underpinning margin expansion potential.
Conclusion
Manulife’s Q2 2026 performance reflects disciplined execution across its diversified portfolio, with Asia and Global WAM driving growth and profitability. The innovative long-term care reinsurance transaction and accelerated AI adoption highlight strategic adaptability. While Canada and U.S. insurance experience challenges persist, management’s targeted actions and capital discipline provide a solid foundation for sustainable value creation.
Industry Read-Through
Manulife’s results and strategic moves exemplify broader industry trends toward risk transfer innovation, AI integration, and multi-channel distribution expansion in insurance. The biometric risk-only reinsurance structure may become a model for managing legacy liabilities while preserving asset management scale. AI’s role as a critical enabler of operational efficiency and customer experience is increasingly evident across financial services. Additionally, regulatory scrutiny in Asian insurance markets underscores the need for agility and diversification in global insurance strategies. Asset managers should note the mixed net flow dynamics, emphasizing the importance of institutional mandates amidst retail and retirement outflows.